I posted a while back about my struggles with the decision about whether to bank my son’s cord blood. My doctor did give me the information he promised, and I have been researching like crazy.
During my research, I stumbled upon one small study that was performed at the University of Florida in 2007. You can read about the study here.
In the study, seven recently diagnosed children between the ages of two and seven were infused with their own cord blood and then their outcomes were compared with 13 children with similar ages and disease durations who received traditional treatment.
After six months, the children who received the transfusions had lower average A1Cs (7% compared to 8.04% in the control group), and they required significantly less insulin per kilogram of body weight. They also had about the same C-peptide levels after the six months as they did at the beginning of the study. This indicates that their beta cells might be living longer and continuing to produce insulin. However, the study did not indicate how their C-peptide levels compared to the levels in the control group.
The conclusion from the study was that cord blood infusion might be useful in newly diagnosed children because it can slow down the progression of the disease, which can lead to tighter control and reduce or prevent the resulting complications.
Of course, this conclusion was determined after just six months. Who knows how these children are doing today, nearly three years later? I looked for an update online, but could not find anything. I did hear from the father of a participant in the study on TuDiabetes, who says his son is still in the “honeymoon phase” after three years. He does admit that his son was one of the better performers in the study. You can read this father’s opinion here.
The report goes on to conclude that it is cost-prohibitive to bank the cord blood of all potential type 1 diabetic children. Instead, the goal of the research is to pinpoint what part of the cord blood is providing the benefit. The theory is that the regulatory T cells in the cord blood prompt a type of immune regulation. Surprisingly, the team thinks that the effect has nothing to do with the stem cells and their ability to become beta (insulin producing) cells. Instead, it is about the regulatory T cells, of which cord blood has a rich supply. These cells seem to somehow neutralize the body’s attack on the beta cells.
Nevertheless, all of the big-name organizations, including the JDRF and the American Academy of Pediatrics, do not recommend private cord blood banking at this time. The evidence to support it is simply not there.
I’m still researching, though, and I’ll let you know what I find. My mind tells me that private banking is a big waste of money — it’s a longshot that we would ever use the blood anyway. But my heart tells me that it would be an awful big gamble not to save this valuable resource.
Resources:
- First Use of Cord Blood to Alter Course of Type 1 Diabetes from the American Diabetes Association, http://parentsguidecordblood.org/content/media/m_pdf/ADA_T1D_PR-06-25-07.pdf
- Parent’s Guide to Cord Blood Foundation Website, http://parentsguidecordblood.org/content/usa/medical/diseases.shtml
- The Therapeutic Potential of Stem Cells From Umbilical Cord Blood on the JRDF’s website, http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=643CEBB4-110A-9BB5-F870BEF6B544DD2A
- Cord blood may preserve insulin levels in children with type 1 diabetes in University of Florida News at http://news.ufl.edu/2007/06/25/cord-blood/
- Cord Blood Banking for Potential Future Transplantation on the American Academy of Pediatrics Website, http://aappolicy.aappublications.org/cgi/content/full/pediatrics;119/1/165
- ACOG Revises Opinion on Cord Blood Banking on the website for the American Congress of Obstetricians and Gynecologists, http://www.acog.org/from_home/publications/press_releases/nr02-01-08-2.cfm